Coinbase Co-Founder’s Longevity Startup NewLimit Raises $435M for Human Trials

The post Coinbase Co-Founder’s Longevity Startup NewLimit Raises $435M for Human Trials appeared first on Coinpedia Fintech News

NewLimit, a longevity biotechnology company co-founded by Coinbase CEO Brian Armstrong, has raised $435 million in a Series C funding round led by Founders Fund. New investors, including Thrive Capital, Greenoaks and Quiet Capital, joined existing backers such as Kleiner Perkins and Eli Lilly Ventures. The company develops age-reprogramming therapies designed to restore cell function …